[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":10753000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":505000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_1_Q3_USD":1420000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_3_Q3_USD":4192000.0,"OtherLiabilitiesCurrent_0_Q3_USD":2044000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":737000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-393000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1128000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":1137000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3068000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6094000.0,"PrepaidInsurance_0_Q3_USD":2975000.0,"PrepaidRent_0_Q3_USD":228000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":215689000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":625000.0,"ProductWarrantyAccrualClassifiedCurrent_0_Q3_USD":1646000.0,"ProductWarrantyExpense_3_Q3_USD":2164000.0,"ProfitLoss_3_Q3_USD":4192000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":6472000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":4982000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":34000.0,"OtherAssetsNoncurrent_0_Q3_USD":1297000.0,"OtherAssetsCurrent_0_Q3_USD":95000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":117000.0,"Liabilities_0_Q3_USD":51125000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":454320000.0,"LiabilitiesCurrent_0_Q3_USD":30014000.0,"LitigationReserveNoncurrent_0_Q3_USD":12633000.0,"MarketingAndAdvertisingExpense_1_Q3_USD":513000.0,"MarketingAndAdvertisingExpense_3_Q3_USD":1200000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":361028000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":213542000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-2697000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":6078000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-818000.0,"NetIncomeLoss_3_Q3_USD":4192000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":346000.0,"NoncurrentAssets_0_Q3_USD":4982000.0,"NonoperatingIncomeExpense_1_Q3_USD":-822000.0,"NonoperatingIncomeExpense_3_Q3_USD":-2346000.0,"OperatingExpenses_1_Q3_USD":18380000.0,"OperatingExpenses_3_Q3_USD":47668000.0,"OperatingIncomeLoss_1_Q3_USD":2897000.0,"OperatingIncomeLoss_3_Q3_USD":7840000.0,"NetIncomeLoss_1_Q3_USD":1420000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":17366000.0,"RestrictedCash_0_Q3_USD":null,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-18415000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":82765000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":6001978.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":9.55,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q3_USD":323000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3_Q3_USD":628000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":0.5,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.32,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":2.58,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":12.97,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":6.58,"StandardProductWarrantyAccrual_0_Q3_USD":1646000.0,"StockholdersEquity_0_Q3_USD":403195000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":1265730.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":264000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q3_USD":34000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_3_Q3_USD":-4192000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q3_USD":-1074000.0,"VariableInterestEntityOwnershipPercentage_3_Q3_pure":0.5,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":62095275.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":113637377.0,"StandardProductWarrantyAccrualWarrantiesIssued_3_Q3_USD":2841000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1760000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":8924536.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":10.43,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":34376000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":89056000.0,"RevenueRemainingPerformanceObligation_0_Q3_USD":13626000.0,"Revenues_1_Q3_USD":34376000.0,"Revenues_3_Q3_USD":89056000.0,"SalesAndExciseTaxPayableCurrent_0_Q3_USD":649000.0,"SellingAndMarketingExpense_1_Q3_USD":6553000.0,"SellingAndMarketingExpense_3_Q3_USD":16406000.0,"SettlementLiabilitiesCurrent_0_Q3_USD":7405000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":14597000.0,"ShareBasedCompensation_3_Q3_USD":3578000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.9007,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.0088,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0095,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":66832000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2922558.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":0.47,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":294726.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":4315589.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":12.56,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.8983,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":57534080.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2453000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":2145000.0,"CashFDICInsuredAmount_0_Q3_USD":250000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"CommonStockSharesIssued_0_Q3_shares":133725741.0,"CommonStockSharesOutstanding_0_Q3_shares":133725741.0,"CommonStockValue_0_Q3_USD":125000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":1454000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":4697000.0,"ContractWithCustomerLiability_0_Q3_USD":14188000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":13626000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":13099000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":33548000.0,"DeferredOfferingCosts_0_Q3_USD":0.0,"DeferredRevenue_0_Q3_USD":18028000.0,"DeferredRevenueCurrent_0_Q3_USD":5885000.0,"DeferredRevenueNoncurrent_0_Q3_USD":7741000.0,"DeferredRevenueRevenueRecognized1_3_Q3_USD":11585000.0,"DeferredTaxAssetsDeferredIncome_0_Q3_USD":7378000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":210652000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":376771000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":376771000.0,"Cash_0_Q3_USD":15743000.0,"AccountsPayableTradeCurrent_0_Q3_USD":3927000.0,"AccountsReceivableNetCurrent_0_Q3_USD":29450000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":6617000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":493000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":10753000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1199000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1490000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":570000.0,"AdditionalPaidInCapital_0_Q3_USD":420600000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":205000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2455000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":3578000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":3000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_3_Q3_USD":172000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":2000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":4000.0,"Assets_0_Q3_USD":454320000.0,"AssetsCurrent_0_Q3_USD":439826000.0,"AssetsFairValueDisclosure_0_Q3_USD":361028000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":309000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2455000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":572000.0,"Depreciation_1_Q3_USD":192000.0,"Depreciation_3_Q3_USD":553000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":6637000.0,"IncreaseDecreaseInInventories_3_Q3_USD":4838000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5002000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":5314945.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":4561195.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":361000.0,"InterestExpense_1_Q3_USD":441000.0,"InterestExpense_3_Q3_USD":1249000.0,"InventoryFinishedGoods_0_Q3_USD":10155000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2099000.0,"InventoryGross_0_Q3_USD":27511000.0,"InventoryRawMaterials_0_Q3_USD":15366000.0,"InventoryWorkInProcess_0_Q3_USD":1990000.0,"InventoryWriteDown_3_Q3_USD":-333000.0,"InvestmentIncomeInterest_1_Q3_USD":12000.0,"InvestmentIncomeInterest_3_Q3_USD":31000.0,"LeaseAndRentalExpense_1_Q3_USD":442000.0,"LeaseAndRentalExpense_3_Q3_USD":1300000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":17404000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2104000.0,"InventoryNet_0_Q3_USD":27511000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2208000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":11647000.0,"IncomeTaxReceivable_0_Q3_USD":1373000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":557000.0,"EarningsPerShareBasic_1_Q3_USD":0.0032,"EarningsPerShareDiluted_1_Q3_USD":0.003,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.316,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.237,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":625000.0,"EquitySecuritiesFvNiGainLoss_3_Q3_USD":40000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":494000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":855000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":486000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":361000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":13896000.0,"Goodwill_0_Q3_USD":476000.0,"GrossProfit_1_Q3_USD":21277000.0,"GrossProfit_3_Q3_USD":55508000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":2075000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":5494000.0,"IncomeTaxesPaidNet_3_Q3_USD":2238000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":655000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":1302000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5749000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":108322433.0,"Ticker":"CTKB","CIK":"1831915","name":"CYTEK BIOSCIENCES, INC.","OfficialName":"Cytek Biosciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1397462385.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]